Bloomage Biotech(SH:688363) Zheng Xing Xing Ye Ri Bao·2025-11-26 09:12Market Overview - The medical beauty sector experienced a decline of 1.18% on November 26, with Huaxi Biological leading the drop [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] Stock Performance - The following table summarizes the performance of key stocks in the medical beauty sector: - ST Meigu (000615): Closed at 4.22, up 2.43%, with a trading volume of 172,400 shares and a turnover of 73.15 million yuan [1] - Jinbo Biological (920982): Closed at 216.31, down 0.22%, with a trading volume of 5,954 shares and a turnover of 129 million yuan [1] - Aimeike (300896): Closed at 145.05, down 0.34%, with a trading volume of 25,100 shares and a turnover of 3.66 million yuan [1] - Huaxi Biological (688363): Closed at 48.30, down 2.72%, with a trading volume of 29,400 shares and a turnover of 144 million yuan [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 7.79 million yuan from main funds, while retail funds experienced a net outflow of 3.70 million yuan [1] - The following table details the capital flow for specific stocks: - ST Meigu (000615): Main funds net inflow of 3.25 million yuan (4.44%), retail funds net outflow of 4.04 million yuan (-5.52%) [2] - Aimeike (300896): Main funds net outflow of 1.66 million yuan (-0.45%), retail funds net outflow of 1.76 million yuan (-0.48%) [2] - Jinbo Biological (920982): Main funds net outflow of 7.97 million yuan (-6.17%), retail funds net outflow of 4.74 million yuan (-3.67%) [2] - Huaxi Biological (688363): Main funds net outflow of 9.37 million yuan (-6.52%), retail funds net inflow of 2.10 million yuan (1.46%) [2]